Skip to content

Sichenzia Ross Friedman Ference LLP Represents Aegis Capital as Underwriter on $3.0M Public Offering

Sichenzia Ross Friedman Ference LLP Advises Underwriter Aegis Capital on U.S. Initial Public Offering of Israeli Biopharmaceutical Company

Sichenzia Ross Friedman Ference LLP Advises DelMar Pharmaceuticals on $2.5M Registered Direct Offering

Sichenzia Ross Friedman Ference LLP Represents Trovagene, Inc. on $40.3M Public Offering of Common Stock

Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals Holding Corp. on $20.1M Public Offering

Sichenzia Ross Friedman Ference LLP Represents Cynata on A$5.0M Private Placement

Sichenzia Ross Friedman Ference LLP Represents Israeli-Based Wellsense on $2.0M Private Placement

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. on $2.1 million Secondary Public Offering of Intellicheck Mobilisa, Inc.

Sichenzia Ross Friedman Ference LLP Represents LaidLaw & Company (UK) Ltd. on $5.0M Registered Direct Offering of Actinium Pharmaceuticals, Inc

Calpian Inc.

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Co. (UK) Ltd. as Sole Book-Running Manager of Viking Therapeutics’ $24.0M IPO

Sichenzia Ross Friedman Ference LLP Represents Ladenburg Thalmann as Placement Agent on Dynatronics’ $4.0M PIPE

Sichenzia Ross Friedman Ference LLP Advises Amarantus on $5M PIPE Investment from Discover Growth Fund

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. as Underwriter for Professional Diversity Network’s $5.0M Public Offering

Sichenzia Ross Friedman Ference LLP Advises Pegasi Energy Resources Corp. on $1.85M PIPE

Sichenzia Ross Friedman Ference LLP Advises Cell Source, Inc. on $500,000 PIPE Financing

Sichenzia Ross Friedman Ference LLP Represents SITO Mobile in $3.7M Acquisition of Hipcricket Inc.’s Mobile Advertising Business

Sichenzia Ross Friedman Ference LLP Advises Can-Fite Biopharmaceuticals on Multi-Million Dollar Licensing Agreement with Cipher Pharmaceuticals

Sichenzia Ross Friedman Ference LLP Advises Citius Pharmaceuticals, LLC on $270,000 PIPE Financing

Sichenzia Ross Friedman Ference LLP Advises Dais Analytic Corporation on $2.75M Common Stock PIPE Financing

Sichenzia Ross Friedman Ference LLP Advises Solar3D on $12.5M Public Offering of Units and Uplisting to the NASDAQ Capital Market